|
|
Volumn 19, Issue 16, 2000, Pages 2079-2087
|
|
Evaluation of a combination drug with multiple doses in unbalanced factorial design clinical trials
a
a
CDER
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BIOSTATISTICS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE CALCULATION;
DRUG EFFICACY;
DRUG RESEARCH;
FACTORIAL ANALYSIS;
HUMAN;
MAJOR CLINICAL STUDY;
PHASE 3 CLINICAL TRIAL;
POLYPHARMACY;
PROBABILITY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SAMPLE;
STATISTICAL ANALYSIS;
SYSTEM ANALYSIS;
ALGORITHMS;
ANALYSIS OF VARIANCE;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
DATA INTERPRETATION, STATISTICAL;
DIURETICS;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPERTENSION;
MODELS, STATISTICAL;
MONTE CARLO METHOD;
PHARMACEUTICAL PREPARATIONS;
PLACEBOS;
POISSON DISTRIBUTION;
PROBABILITY;
RANDOMIZED CONTROLLED TRIALS;
SAMPLE SIZE;
|
|
EID: 0034734389
PISSN: 02776715
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0258(20000830)19:16<2079::AID-SIM535>3.0.CO;2-I Document Type: Review |
|
Times cited : (16)
|
|
References (8)
|
